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RV Is Doing Well at High Altitudes!dAlways?*
Robert Naeije, MDBrussels, BelgiumAltitude exposure has long been recognized as a
cardiac stress. Early accounts of alpine climbs
mention a diagnosis of “cardiac fatigue” based on
tachycardia, palpitations, shortness of breath, and
chest percussion (fonendoscopy) of enlarged hearts
(1). Heart failure syndromes have been reported at
high altitudes under various names including brisket
disease in cattle brought to high-altitude pastures in
Utah and Colorado (2), chronic mountain sickness
(CMS) or Monge’s disease in the inhabitants of the
South American altiplano (3), less frequently in Han
Chinese immigrants to Tibet (4), subacute moun-
tain sickness corresponding to a form of rapidly
evolving right ventricular failure observed in Indian
soldiers posted at the high-altitude borders in China
(5), in Han Chinese infants brought to reside in
Tibet (6), and occasional echocardiographic high-
altitude right heart failure in previously healthy
travelers (7). When diagnosed at high altitudes,
heart failure is almost always predominantly right
sided. This is explained by hypoxic pulmonary
vasoconstriction and remodeling as a cause of
increased right ventricular (RV) afterload and
possibly a contribution of negative inotropic effects
of ambient hypobaric hypoxia (8).See page 1287In this context, the report by Pratali et al. (9) in
this issue of iJACC, of normal cardiac adaptation to
exercise in high-altitude dwellers with CMS may
appear provocative, but what is the exact meaning of
CMS? A recent expert consensus conference deﬁned
CMS as a syndrome of chronic maladaptation to*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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relevant to the contents of this paper to disclose.altitude characterized by symptomatic polycythemia
(with hemoglobin >21 g/l in men and >19 g/l in
women), severe hypoxemia, and relative hypo-
ventilation with or without pulmonary hypertension
and eventual right ventricular failure (10). Thus,
although (right) heart failure is generally thought to
be an inescapable consequence of CMS, it is not
necessarily present at diagnosis, and it is unclear as
to how often heart failure complicates CMS. As for
pulmonary hypertension in CMS, it is variable, more
often mild to moderate than severe, in proportion to
decreased arterial oxygenation (11) and increased
viscosity of the blood (12). Pulmonary hypertension
in CMS is exacerbated by exercise, with steep
pressure-ﬂow relationships and pulmonary artery
pressures reaching systemic levels in a proportion of
patients (11–13). Nonetheless, this is still not heart
failure. There is thus a confusion of terms in the
literature about the cardiac complications of high-
altitude exposure that should be better clariﬁed
with help of more data at a next expert consensus
meeting.
Pratali et al. (9) measured pulmonary vascular
pressures, cardiac output, and indexes of RV and left
ventricular (LV) function and dimensions using
Doppler echocardiography and tissue Doppler im-
aging at rest and at exercise. Their study included 46
patients with CMS and 41 healthy controls all living
permanently at the altitude of 3,600 to 4,000 m in
La Paz, Bolivia. Pulmonary artery pressures at rest
were on average at the upper limit of normal (at sea
level) in both groups, but increased markedly at
exercise, as expected. Pulmonary vascular resistance
(PVR) increased in the CMS patients and remained
unchanged in the control subjects, in contrast to the
decrease in PVR due to the distensibility of resistive
vessels normally seen in healthy subjects at sea
level (14).
Indexes of resting RV or LV function measured
by Pratali et al. (9) did not differ between CMS
patients and control subjects, with the exception of
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1299some increase in RV dimensions and decreased
fractional area change (estimating ejection fraction)
in the CMS patients. In agreement with previous
studies, both healthy control subjects and CMS
patients had a few slight alterations in indexes of
LV and RV diastolic and systolic function, in-
cluding the Tei index, compared with reported
measurements in healthy sea level volunteers
(15–18). However, RV contractility (assessed by
end-systolic [actually peak systolic] pressure vs. area)
increased during exercise in adaptation to increased
loading conditions, indicating preserved contractile
reserve. Similar results with validation of the end-
systolic pressure to area ratio against magnetic
resonance imaging have been recently reported in
healthy subjects at sea level (19). It is of interest that
the tissue Doppler imaging of RV myocardial ac-
celeration during isovolumic contraction also
increased during exercise, in contrast to unchanged
or decreased fractional area change. Isovolumic
phase indexes of systolic function have been shown
to be relatively load independent, and thus more
tightly correlated with gold-standard end-systolic
elastance than ejection fraction (20). Thus, the right
ventricle is able to respond to exercise at high altitudes
by increased contractility, preserving RV-arterial
coupling despite markedly increased pulmonary ar-
tery pressures. This result is in keeping with recent
report of preserved aerobic exercise capacity in CMS
patients compared with healthy high-altitude
dwellers or recently acclimatized lowlanders (13).
Thus, the heart seems to be coping well at high alti-
tudes, with or without CMS symptoms.
Is it always so? The answer is no. High-altitude
exposure may be a cause of right heart failure
in patients with severe pulmonary hypertension. The
risk of it is probably restricted to w1% ofpreviously healthy individualswith pulmonary vascular
hyper-reactivity to hypoxia and subsequent severe
hypoxic pulmonary hypertension (8,12). Even so,
high-altitude dwellers have been reported to lead
normal active lives despite very high pulmonary artery
pressures (21). This is also seen in patients with
severe pulmonary arterial hypertension (idiopathic
or associated to congenital heart diseases) in whom
the right ventricle sometimes remains adequately
coupled to a hypertensive pulmonary circulation for
extensive periods of time. The understanding of the
pathobiology of RV function adaptation and eventual
failure in severe pulmonary hypertension remains a
challenge (22). Extramyocardial factors may also have
to be taken into consideration. Fluid retention may
be aggravated by relatively higher arterial PCO2 in
CMS patients as a cause of increased renal reabsorp-
tion of sodium and bicarbonate (12). Whether pre-
conditioning of the right ventricle occurs in physically
active mountaineers as in highly trained endurance
athletes (19) would be interesting to investigate.
Pratali et al. (9) are to be commended for their
elegant noninvasive study showing that the (right)
heart at high altitudes is most often well adapted with
preserved contractile reserve. However, as always in
medicine, exceptions occur that may be of even
greater pathophysiological interest than the rules.
More research with clearer deﬁnitions and concepts
is needed in this fascinating area. In the meantime,
the risk of high-altitude–induced right heart failure
should not be neglected by cautious clinicians
advising high-altitude dwellers and travelers.
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